In vivo effects of bempedoic acid on microdosed CYP probe drugs
Sign Up to like & getrecommendations! Published in 2025 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2025.1544956
Abstract: Background Bempedoic acid (BA) is a novel oral cholesterol-lowering drug. So far, in vivo evidence on potential drug–drug interactions via the cytochrome P450 (CYP) enzymes is lacking. Methods In a clinical trial, we evaluated the… read more here.
Keywords: vivo effects; probe drugs; bempedoic acid; dose evaluate ... See more keywords